• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery

    4/17/25 9:15:00 AM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email

    SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), today announced the publication of two studies showing how the availability of RAS helps enable access to high-quality care, improve patient outcomes, particularly in medical deserts, and contributes to the overall growth of minimally invasive care ultimately benefitting patients.

    The studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons and Annals of Surgery Open, are part of broader research underway by Intuitive to evaluate the availability and impact of RAS. As a leader in minimally invasive care, Intuitive is committed to identifying gaps in patient access and collaborating with healthcare providers to help them expand access and measure outcomes through evidence generation.

    Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?

    The first study, titled "Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?" identified regions where patients lack access to high-quality MIS due to factors such as training availability, location, and/or hospital infrastructure. The study also examined how RAS can enable more widespread and efficient adoption of minimally invasive care.

    "Minimally invasive surgery offers profound benefits for patients, from shorter recovery times to reduced postoperative complications, yet too many patients lack access due to barriers like surgeon training or hospital location," said Intuitive's Chief Medical Officer Myriam Curet, M.D. "This paper underscores the need for innovative solutions to give hospitals and surgeons more options to improve patient care and outcomes."

    Key findings from this article, authored by a multidisciplinary team including Intuitive, include:

    • Defining MIS Deserts: A medical desert is an area where patients lack access to health services. There are multiple barriers to MIS access, and patients in these areas may undergo open surgery more often, missing out on the benefits of MIS.
    • Identifying Barriers to MIS Access: Surgeon characteristics, including training, board certification, years of practice, and procedure volume, accounted for nearly two-thirds of variation in MIS use for colectomy. Patient sociodemographic characteristics accounted for nearly 30 percent, and hospital characteristics, such as rural or urban location, academic status, and procedure volume accounted for about 7 percent.
    • Impact of Robotic-Assisted Surgery: Addressing surgeon training could result in significant improvement in MIS use. RAS offers surgeons a shorter learning curve compared to traditional laparoscopy, allowing clinicians to become proficient more quickly. Telementoring and remote surgical support could further extend the reach of experienced surgeons into underserved areas.

    Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations

    Building on the previous study, "Rates of Minimally Invasive Surgery after Introduction of Robotic-Assisted Surgery for Common General Surgery Operations," examined how the introduction of RAS has influenced rates of MIS in hospitals across the United States. The study also evaluated whether adopting RAS helped expand access to MIS across different demographics, including age, sex, race, ethnicity, and insurance status.

    The study evaluated data from 408 U.S. hospitals between 2016 and 2022, focusing specifically on 153 hospitals that introduced RAS for common general surgeries such as cholecystectomy, hernia repair, and colorectal resection. The findings highlight the broader impact of RAS adoption on minimally invasive surgery rates:

    • Higher MIS Adoption: Hospitals that implemented RAS saw MIS rates increase from 60.5% to 65.8%, a significantly greater rise than hospitals that did not introduce RAS (56.1% to 57.0%).
    • Expanded Access Across Patient Populations: Patients aged 35 and older and those with Medicare or commercial insurance saw significant MIS rate increases, suggesting a broader reach of minimally invasive techniques.
    • Consistent Gains Across Procedures: The greatest MIS gains in RAS hospitals were seen in hernia repairs and colorectal resections, where rates outpaced those in non-RAS hospitals.

    Prior studies have debated whether the rise of RAS primarily shifts procedures from laparoscopy rather than expanding MIS access. This research adds to the body of evidence suggesting that, in many hospitals, the introduction of RAS contributes to overall MIS growth across populations rather than redistributing surgical methods by overcoming some of the barriers associated with laparoscopy, including ergonomic limitations and 2D visualization.

    "These findings suggest that the introduction of robotic-assisted surgery is helping to expand patient access to minimally invasive techniques," said Zhi Ven Fong, MD, MPH, DrPH, co-author, hepatobiliary and pancreas surgeon, and surgical oncologist, Division of Surgical Oncology and Endocrine Surgery, Mayo Clinic Arizona. "By removing some of the technical challenges of traditional laparoscopy, RAS has the potential to make minimally invasive surgery a more viable option for a broader range of patients."

    To date, more than 16 million patients have benefitted from minimally invasive care performed with Intuitive technologies including urology, gynecology, colorectal, general surgery, thoracic, and cardiac surgery procedures and has helped improve patient outcomes, ranging from shorter recovery times to reduced postoperative complications, depending on the procedure and individual patient characteristics.

    For more information about Intuitive's efforts to help advance greater access to care and specifically robotic-assisted surgery, visit www.intuitive.com.

    References:

    1. Mitzman, Brian et al. "Minimally Invasive Surgery Deserts: Is There a Role for Robotic Assisted Surgery?." JSLS : Journal of the Society of Laparoendoscopic Surgeons vol. 28,3 (2024): e2024.00039. doi:10.4293/JSLS.2024.00039



    2. Fong, Zhi Ven et al. "Rates of Minimally Invasive Surgery After Introduction of Robotic-Assisted Surgery for Common General Surgery Operations." Annals of surgery open : perspectives of surgical history, education, and clinical approaches vol. 6,1 e546. 31 Jan. 2025, doi:10.1097/AS9.0000000000000546

    Contact: Megan Elliott, Intuitive

    [email protected]

    1-669-222-9899

    About Intuitive

    Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

    About da Vinci Surgical Systems

    There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

    For more information, please visit the company's website at www.intuitive.com.

    Important Safety Information

    For product intended use and/or indications for use, risks, cautions, and warnings and full prescribing information, visit https://manuals.intuitivesurgical.com/market. For summary of the risks associated with surgery refer to www.intuitive.com/safety.



    Primary Logo

    Get the next $ISRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    5/30/2024$500.00Buy
    Goldman
    11/17/2023$318.00Buy
    HSBC Securities
    7/19/2023$377.00Outperform
    Robert W. Baird
    4/19/2023$240.00 → $270.00In-line
    Evercore ISI
    4/19/2023$305.00 → $317.00Buy
    Citigroup
    More analyst ratings

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

      SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP's capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorec

      5/1/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • New Research Explores Access to Minimally Invasive Care and the Impact of Robotic-Assisted Surgery

      SUNNYVALE, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS), today announced the publication of two studies showing how the availability of RAS helps enable access to high-quality care, improve patient outcomes, particularly in medical deserts, and contributes to the overall growth of minimally invasive care ultimately benefitting patients. The studies, published in the Journal of the Society of Laparoscopic & Robotic Surgeons and Annals of Surgery Open, are part of broader research underway by Intuitive to evaluate the availability and impact of RAS. As a leader in minimally in

      4/17/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Financials

    Live finance-specific insights

    See more
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Fourth Quarter Earnings

      SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024. Q4 Highlights Worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.The Company placed 493 da Vinci surgical systems, compared with 415 in the fourth quarter of 2023. The fourth quarter 2024 da Vinci surgical system placements included 174 da Vinci 5 systems.The Company grew its da Vinci surgical system installed base to 9,902 systems as of December 31, 2024, an increase of 15%

      1/23/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

      SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2024 financial results ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. Financial and Operational Highlights Fourth quarter 2024 worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.Full year 2024 worldwide da Vinci procedures grew approximately 17% compared with 2023. The Company expects worldwide da Vinci procedures to i

      1/15/25 9:00:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Intuitive Surgical upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Intuitive Surgical from Equal-Weight to Overweight and set a new price target of $650.00 from $522.00 previously

      12/2/24 6:57:53 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Redburn Atlantic with a new price target

      Redburn Atlantic upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $510.00 from $380.00 previously

      8/2/24 7:32:46 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Citigroup reiterated coverage on Intuitive Surgical with a new price target

      Citigroup reiterated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $512.00 from $462.00 previously

      7/10/24 8:37:42 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    See more

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ISRG
    SEC Filings

    See more
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance
    • Astera Labs Appoints Dr. Craig Barratt to Board of Directors

      SANTA CLARA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (NASDAQ:ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced the appointment of Dr. Craig Barratt to its Board of Directors. Dr. Barratt is a seasoned technology industry veteran with decades of experience as an impactful leader and board member at networking, semiconductor, and medical device companies. "Craig's proven track record of scaling high-growth technology companies and driving breakthrough innovations at industry leaders like Atheros, Google, and Qualcomm makes him an invaluable addition to Astera Labs' Board of Directors," said Jitendra Moh

      3/3/25 4:05:00 PM ET
      $ALAB
      $ISRG
      Semiconductors
      Technology
      Industrial Specialties
      Health Care
    • Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

      SAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th

      10/28/24 7:00:00 AM ET
      $ISRG
      $PRCT
      $SNBR
      $SWAV
      Industrial Specialties
      Health Care
      Medical/Dental Instruments
      Home Furnishings
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/24 10:02:59 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/23 12:37:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/9/23 11:22:22 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Officer Samath Jamie exercised 915 shares at a strike of $259.91 and sold $483,074 worth of shares (915 units at $527.95) (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/5/25 4:43:58 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form 4 filed by Director Reed Monica P

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/1/25 9:19:26 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Director Nachtsheim Jami K exercised 2,400 shares at a strike of $90.49 and sold $1,248,000 worth of shares (2,400 units at $520.00) (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      5/1/25 9:12:35 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/5/25 9:00:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form 10-Q filed by Intuitive Surgical Inc.

      10-Q - INTUITIVE SURGICAL INC (0001035267) (Filer)

      4/23/25 5:13:16 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      4/22/25 4:03:30 PM ET
      $ISRG
      Industrial Specialties
      Health Care